 The vaccination regime consists of primary 10 intradermal injections of 1-2 weeks interval q1w x 4 q2w x 6 with p53 peptide-pulsed dendritic cells, followed by monthly injections until progression; proleukin and Zadaxin are used as vaccine adjuvants. 